Significance of brain natriuretic peptide in the evaluation of symptoms and the degree of left ventricular diastolic dysfunction in patients with hypertrophic cardiomyopathy

Hellenic Journal of Cardiology

Volumn 47, Issue 6, 2006, Pages 344-351

  Panou, Fotis K ^a   Kotseroglou, Vasiliki K ^a,b   Lakoumentas, John A ^a   Chrysanthopoulou, Stavroula A ^b   Armeniakos, John A ^a   Stratigou, Theodora ^a   Veve, Helen ^a   Zacharoulis, Apostolos A ^a  

^a IASO GENERAL HOSPITAL   (Greece)

^b Polikliniki General Hospital ^*

Author keywords

Echocardiography; Tissue Doppler imaging

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DYSPNEA; HEART DISEASE; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE OUTFLOW TRACT; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MEASUREMENT; MITRAL VALVE REGURGITATION; MULTIPLE REGRESSION; PATIENT ASSESSMENT; BLOOD; ECHOGRAPHY; FEMALE; HEART LEFT VENTRICLE FUNCTION; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; REGRESSION ANALYSIS; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; CARDIOMYOPATHY, HYPERTROPHIC; FEMALE; HUMANS; MALE; MIDDLE AGED; MITRAL VALVE INSUFFICIENCY; NATRIURETIC PEPTIDE, BRAIN; REGRESSION ANALYSIS; SENSITIVITY AND SPECIFICITY; VENTRICULAR DYSFUNCTION, LEFT;

EID: 34247117870     PISSN: 10117970     EISSN: 10117970     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. McCullough PA, Nowak RM, McCord, et al: B-type natriuretic peptide and clinical judgement in emergency diagnosis of heart failure, analysis of heart failure, analysis from Breathing Not Properly (BNP) Multinational Study. Circulation 2002; 106: 416-422.
2. Logeart D, Thabut G, Jourdain P, et al: Predischarge B-type natriuretic peptide assay for identifying patients at high risk of readmission after decompensated heart failure. J Am Coll Cardiol 2004; 43: 635-641.
3. Maisel AS: B-type Natriuretic Peptide (BNP) levels. Diagnostic and Therapeutic Potential. Review. Rev Cardiovasc Med 2001; 2(Supp 2): S13-S18.
4. Nigishaki K, Tomita M, Kagawa K, et al: Marked expression of plasma brain natriuretic peptide is a special feature of hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol 1996; 28: 1234-1242.
5. Takemura G, Fujiwara H, Mukoyama M, et al: Expression and distribution of atrial natriuretic polypeptide in human hypertrophic ventricle of hypertensive hearts with hypertrophic cardiomyopathy. Circulation 1991; 83: 181-190.
6. Hasegawa K, Fujiwara H, Doyama K, et al: Ventricular expression of brain natriuretic peptide in hypertrophic cardiomyopathy. Circulation 1993; 88: 372-380.
7. Briguori C, Bettochi S, Manganelli F, et al: Determinants and clinical significance of natriuretic peptides in hypertrophic cardiomyopathy. Eur Heart J 2001; 22: 1328-1336.
8. Maron BJ, Tholakanahalli VN, Zenovich AG, et al: Usefulness of B- type natriuretic peptide assay in the assessment of symptomatic state in hypertrophic cardiomyopathy. Circulation 2004; 109: 984-989.
9. Maron BJ, Bonow RO, Cannon RO, et al: Hypertrophic cardiomyopathy: interrelations of clinical manifestations, pathophysiology and therapy. N Engl J Med 1987; 316: 780-784.
10. Maron BJ, McKenna WJ, Danielson GK, et al: American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy. Eur Heart J 2003; 24: 1965-1991.
11. Boomsma F, Deinum J, van den Meiracker AH: Relationship between natriuretic peptide concentrations in plasma and posture during blood sampling. Clinical Chemistry 2001; 47: 963-965.
12. Brun P, Tribouilloy C, Duval AM, et al: Left ventricular flow propagation during early filling is related to wall relaxation: a colour M-mode Doppler analysis. J Am Coll Cardiol 1992; 20: 420-432.
13. Nagueh SF, Kopelen HA, Quinones MA: Doppler estimation of left ventricular filling pressures in atrial fibrillation. Circulation 1996; 94: 2138-2145.
14. Garcia MJ, Ares MA, Asher C, et al: An index of early left ventricular filling that combined with pulsed Doppler peak E velocity may estimate capillary wedge pressure. J Am Coll Cardiol 1997; 29: 448-454.
15. Nagueh SF, Lakkis NM, Middleton KJ, et al: Doppler estimation of left ventricular filling pressures in patients with hypertrophic cardiomyopathy. Circulation 1999; 99: 254-261.
16. Rajiv C, Vinerenau D, Fraser A: Tissue Doppler imaging for the evaluation of patients with hypertrophic cardiomyopathy. Curr Opin Cardiol 2004; 19: 430-436.
17. Panza JA, Petrone RK, Fanazapir L, et al: Utility of continuous wave Doppler echocardiography in the non invasive assessment of left ventricular outflow tract pressure gradient in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 1992; 19: 91-99.
18. Zoghbi WA, Enriquez-Sarano M, Foster E, et al: American Society of Echocardiography. Recommendations for the evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 2003; 16: 777-802.
19. Nishimura R, Appleton C, Redfield M, et al: Non invasive Doppler echocardiographic evaluation of left ventricular filling pressures in patients with cardiomyopathies: a simultaneous Doppler echocardiographic and cardiac catheterization study. J Am Coll Cardiol 1996; 28: 1226-1233.
20. Paulus WJ: Editorial comment "Natriuretic peptides to probe hemodynamic overload in hypertrophic cardiomyopathy". Eur Heart J 2001; 22: 1249-1251.